NewLead Holdings Ltd. (NASDAQ:NEWL) that it has previously signed a term sheet with a leading financial institution to provide 75% debt financing for two second-hand Panamax vessels for a total of $35 million. The two vessels are expected to be delivered to NewLead’s fleet within the next three months, subject to the receipt of the necessary financing for the balance of the purchase price. NewLead Holdings Ltd (NASDAQ:NEWL) shares after opening at $1.10moved to $1.19on last trade day and at the end of the day closed at $0.812. Company price to sales ratio in past twelve months was calculated as 0.14. NewLead Holdings Ltd (NASDAQ:NEWL) showed a negative weekly performance of-41.30%.
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced that two scientific poster presentations on the pharmacology of PEGPH20 will be made at the American Association for Cancer Research (AACR) annual meeting being held in San Diego. The first presentation includes preclinical data showing that treatment of tumors with PEGPH20 enhances the action of immune-based cancer therapy such as monoclonal antibodies (mAbs). Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares advanced 0.36% in last trading session and ended the day on $8.29. HALO return on assets ratio is recorded as -76.60%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) yearly performance is 53.52%.
Shares of therapeutic drug development company Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) are tumbling after its clinical study of a drug being tested as a treatment of Alzheimer’s Disease did not hit its primary endpoint. WHAT’S NEW: Prana released the top line results of the 12-month Phase II Imaging trial in Alzheimer’s Disease “IMAGINE” Trial, based on draft results. Prana’s PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer’s disease patients. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares moved up 1.83% in last trading session and was closed at $2.23 while trading in range of $2.13-$2.27 – year to date (YTD) performance is -68.19%.
Ascent Solar Technologies, Inc. (NASDAQ:ASTI), a developer and manufacturer of state-of-the-art, flexible thin-film photovoltaic modules integrated into the company’s EnerPlex(TM) series of consumer products, announced today the immediate availability of the Red Dot design award-winning EnerPlex Jumpr Slate at company owned kiosks, as well as online at www.goenerplex.com. The product will be available at partner retailers both domestically and internationally later this month. Ascent Solar Technologies, Inc. (NASDAQ:ASTI) weekly performance is -6.78%. On last trading day company shares ended up $ 0.548. Ascent Solar Technologies, Inc. NASDAQ:ASTI) distance from 50-day simple moving average (SMA50) is -18.83%. Analysts mean target price for the company is $0.80.